Becton Dickinson And Co logo

BDX - Becton Dickinson And Co Share Price

$242.01 -1.5  -0.6%

Last Trade - 05/06/20

Sector
Healthcare
Size
Large Cap
Market Cap £55.38bn
Enterprise Value £70.24bn
Revenue £13.75bn
Position in Universe 135th / 6325
Bullish
Bearish
Unlock BDX Revenue
Momentum
Relative Strength (%)
1m
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High
50d MA
200d MA
Margin of Safety
Qualifying GuruScreens
Financial Summary
FINANCIAL BRIEF: : For the six months ended 31 March 2020, Becton Dickinson and Co revenues increased 1% to $8.48B. Net income applicable to common stockholders excluding extraordinary items decreased 32% to $385M. Revenues reflect Life Sciences segment increase of 6% to $2.24B, Interventional segment increase of 4% to $2B, United States segment increase of 2% to $4.85B, Internationals segment remaining flat at $3.63B.
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

BDX Revenue Unlock BDX Revenue

Net Income

BDX Net Income Unlock BDX Revenue

Normalised EPS

BDX Normalised EPS Unlock BDX Revenue

PE Ratio Range

BDX PE Ratio Range Unlock BDX Revenue

Dividend Yield Range

BDX Dividend Yield Range Unlock BDX Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2020
31st Dec 2021
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
BDX EPS Forecasts Unlock BDX Revenue
Profile Summary

Becton, Dickinson and Company (BD) is a global medical technology company engaged in the development, manufacture and sale of a range of medical supplies, devices, laboratory equipment and diagnostic products. The Company operates through two segments: BD Medical and BD Life Sciences. The BD Medical segment produces an array of medical technologies and devices that are used to help improve healthcare delivery in a range of settings. BD Medical consists of various business units, including diabetes care, medication and procedural solutions, medication management solutions and pharmaceutical systems. The BD Life Sciences segment provides products for the safe collection and transport of diagnostics specimens, and instruments and reagent systems to detect a range of infectious diseases, healthcare-associated infections and cancers. The Company's BD Life Sciences segment consists of various business units, including preanalytical systems, diagnostic systems and biosciences.

Directors
Last Annual September 30th, 2019
Last Interim March 31st, 2020
Incorporated November 13, 1906
Public Since September 25, 1963
No. of Shareholders: 13,277
No. of Employees: 70,093
Sector Healthcare
Industry Healthcare Equipment & Supplies
Index S&P Composite 1500 , S&P 500 , S&P 500 Health Care (sector),
Exchange New York Stock Exchange
Shares in Issue 289,780,449
Free Float (0.0%)
Eligible for
ISAs
SIPPs
BDX Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for BDX
Upcoming Events for BDX
Monday 8th June, 2020
Dividend For BDX.N - 0.7900 USD
Monday 8th June, 2020
Dividend For B1DX34.SA - 0.8798 BRL
Tuesday 9th June, 2020
Becton Dickinson and Co at Goldman Sachs Global Healthcare Conference (Virtual)
Wednesday 10th June, 2020
Becton Dickinson and Co at William Blair Growth Stock Conference
Tuesday 4th August, 2020 Estimate
Q3 2020 Becton Dickinson and Co Earnings Release
Tuesday 3rd November, 2020 Estimate
Q4 2020 Becton Dickinson and Co Earnings Release
Frequently Asked Questions for Becton Dickinson and Co
What is the Becton Dickinson and Co share price?

As of 05/06/20, shares in Becton Dickinson and Co are trading at $242.01, giving the company a market capitalisation of £55.38bn. This share price information is delayed by 15 minutes.

How has the Becton Dickinson and Co share price performed this year?

Shares in Becton Dickinson and Co are currently trading at $242.01 and the price has moved by 2.27% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Becton Dickinson and Co price has moved by -5.58% over the past year.

What are the analyst and broker recommendations for Becton Dickinson and Co?

Of the analysts with advisory recommendations for Becton Dickinson and Co, there are there are currently 5 "buy" , 7 "hold" and 0 "sell" recommendations. The overall consensus recommendation for Becton Dickinson and Co is Hold. You can view the full broker recommendation list by unlocking its StockReport.

When will Becton Dickinson and Co next release its financial results?

Becton Dickinson and Co is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-03-31
What is the Becton Dickinson and Co dividend yield?

The Becton Dickinson and Co dividend yield is 1.29% based on the trailing twelve month period.

Does Becton Dickinson and Co pay a dividend?

Last year, Becton Dickinson and Co paid a total dividend of 3.12, and it currently has a trailing dividend yield of 1.29%. Looking ahead, shares in Becton Dickinson and Co are due to go ex-dividend on 2020-06-08 and the next dividend pay date is 2020-06-30.

When does Becton Dickinson and Co next pay dividends?

Becton Dickinson and Co are due to go ex-dividend on 2020-06-08 and the next dividend pay date is 2020-06-30. The historic dividend yield on Becton Dickinson and Co shares is currently 1.29%.

How do I buy Becton Dickinson and Co shares?

To buy shares in Becton Dickinson and Co you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Becton Dickinson and Co?

Shares in Becton Dickinson and Co are currently trading at $242.01, giving the company a market capitalisation of £55.38bn.

Where are Becton Dickinson and Co shares listed? Where are Becton Dickinson and Co shares listed?

Here are the trading details for Becton Dickinson and Co:

Country of listing: United States
Exchange: NYQ
Ticker Symbol: BDX
What kind of share is Becton Dickinson and Co?

Based on an overall assessment of its quality, value and momentum, Becton Dickinson and Co is currently classified as a High Flyer. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a Becton Dickinson and Co share price forecast 2020?

Shares in Becton Dickinson and Co are currently priced at $242.01. At that level they are trading at 14.34% discount to the analyst consensus target price of 0.00.

Analysts covering Becton Dickinson and Co currently have a consensus Earnings Per Share (EPS) forecast of 10.456 for the next financial year.

How can I tell whether the Becton Dickinson and Co share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Becton Dickinson and Co. Over the past six months, the relative strength of its shares against the market has been -6.46%. At the current price of $242.01, shares in Becton Dickinson and Co are trading at -4.61% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Becton Dickinson and Co PE Ratio?

The Becton Dickinson and Co PE ratio based on its reported earnings over the past 12 months is 34.48. The shares are currently trading at $242.01.

The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.

The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.

Who are the key directors of Becton Dickinson and Co?

Becton Dickinson and Co's management team is headed by:

Vincent Forlenza - CHM
Christopher Reidy - CFO
James Borzi - EVP
Samrat Khichi - EVP
Thomas Polen - PRE
Betty Larson - CHO
Simon Campion - EVP
Catherine Burzik - IND
Patrick Kaltenbach - EVP
Roland Goette - EVP
Ching leong - EVP
R. Andrew Eckert - IND
Jeffrey Henderson - IND
Claire Fraser - IND
Christopher Jones - IND
Who are the major shareholders of Becton Dickinson and Co?

Here are the top five shareholders of Becton Dickinson and Co based on the size of their shareholding:

The Vanguard Group, Inc. Investment Advisor/Hedge Fund
Percentage owned: 8.3% (24.0m shares)
T. Rowe Price Associates, Inc. Investment Advisor
Percentage owned: 7.57% (21.9m shares)
BlackRock Institutional Trust Company, N.A. Investment Advisor
Percentage owned: 4.32% (12.5m shares)
State Street Global Advisors (US) Investment Advisor/Hedge Fund
Percentage owned: 3.97% (11.5m shares)
Fidelity Management & Research Company Investment Advisor
Percentage owned: 2.96% (8.56m shares)
Similar to BDX
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.